Résumé
Cet article retrace l’évolution d’un axe de recherche spécifique, développé au cours du XXe siècle, qui se voue à élucider l’incidence « du » cancer dans la population « des malades mentaux », et plus particulièrement des sujets psychotiques. Il décrit les ramifications de cette recherche et la précision progressive de ses questions ainsi que des entités diagnostiques qu’elle mobilise pour les poser. Il s’efforce de mettre en lumière le fait que l’appréhension de la question comme un « puzzle épidémiologique » suppose et reflète l’adoption formelle du modèle médical pour penser les maladies mentales et entraîne l’effacement d’un abord clinique des psychopathologies dans la rencontre et l’accompagnement des patients souffrant de cancers.
Abstract
This article is related to the evolution of a specific research, developed during the 20th century. This research is dedicated to assess “the cancer” incidence in the population of “the lunatics”, and more precisely in the “psychotic population”. It describes the paradigm of this research and the progressive definition of its questions. Moreover, it specifies the chosen diagnostic entities that are used in this research development. The highlights that treating the questions as an “epidemiological puzzle” is assuming and reflecting the acquisition of a medical model to think about mental disease. Because of this, in the field of oncology, psychopathology clinical approach has become outdated.
Références
Azoulay J, Souffir V (2005) États psychotiques et maladies somatiques. Considérations historiques et de psychiatrie clinique. Rev Fr Psychosom 27:17–40
Achterberg J, Collerain I, Craig P, et al (1978) A possible relationship between cancer, mental retardation and mental disorders. Soc Sci Med 12:136
Fox BH, Howell MA (1974) Cancer risk among psychiatric patients: a hypothesis. Inter J Epidemiol 3:207–8
Ehrentheil O (1956) Malignant tumors in psychotic patients. I. Studies of Incidence. Arch Neurol Psychiatry 76:529–35
Baldwin JA (1979) Schizophrenia and physical disease. Psychol Med 9:611–8
Mortensen PB (1994) The occurrence of cancer in first admitted schizophrenic patients. Schizophr Res 12:185–94
Lichtermann D, Ekelund J, Pukkala E, et al (2001) Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry 58:573–8
Cohen ME, Dembling B, Schorling JB, et al (2002) The association between schizophrenia and cancer: a population-based mortality study. Schizophr Res 57:139–46
Leucht S, Burkard T, Henderson J, et al (2007) Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 116:317–33
Katz J, Kunovsky S, Patton RE, et al (1967) Cancer mortality among patients in New York mental hospitals. Cancer 20:2194–9
Scheflen AE (1951) Malignant tumors in the institutionnalized psychotic population. Arch Clin Neuropsychol 66:145–55
Grinshponn A, Barchana M, Ponizovsky A, et al (2005) Cancer in schizophrenia: is the risk higher or lower? Schizophr Res 73:331–41
BarChana M, Levav I, Lipshitz I, et al (2008) Enhanced cancer risk among patients with bipolar disorder. J Affect Dis 108:43–8
Levav I, Kohn R, Barchana M, et al (2009) The risk for cancer among patients with schizoaffective disorders. J Affect Dis 114:316–20
Mortensen PB (1989) The incidence of cancer in schizophrenic patients. J Epidemiol Comm Health 43:43–7
Hippisley-Cox J, Vinogradova Y, Coupland C, et al (2007) Risk of malignancy in patients with schizophrenia or bipolar disorder. Arch Gen Psychiatry 64:1368–76
Goldacre MJ, Kurina LM, Wotton CJ, et al (2005) Schizophrenia and cancer: an epidemiological study. Br J Psychiatry 187:334–8
Hodgson R, Wildgust HJ, Bushe CJ, et al (2010) Cancer and schizophrenia: is there a paradox? J Psychopharmacol 24:52
Catts VS, Catts SV, O’Toole BI, et al (2008) Cancer incidence in patients with schizophrenia and their first-degree relatives — a meta-analysis. Acta Psychiatr Scand 117:323–36
Catts VS, Catts SV (2000) Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr Res 41:405–15
Park JK, Lee HJ, Kim JW, et al (2004) Differences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients. Schizophr Res 67:71–4
Lim CH, Zain SM, Reynolds JP, et al (2014) Genetic association of LMAN2L gene in schizophrenia and bipolar disorder and its interaction with ANK3 gene polymorphism. Prog Neuropsychopharmacol Biol Psychiatry 54:157–62
Zenoni A (2009) L’autre pratique clinique. Psychanalyse et institution thérapeutique. Éditions Érès, Toulouse
Gonon F (2011) La psychiatrie biologique: une bulle spéculative? Esprit 11:54–73. (L’auteur précise [p. 56]: « L’analyse du génome entier de près de sept cent cinquante schizophrènes n’a pas suffi pour mettre en évidence des anomalies génétiques »)
Feighner JP, Robins E, Guze SB, et al (1972) Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26:57–63
Kawa S, Giordano J (2012) A brief historicity of the Diagnostic and Statistical Manuel of Mental Disorders: issues and implications for the future of psychiatric canon and practice. Phil Ethics Humanit Med 7:5
Sanders JL (2011) A distinct language and a historic pendulum: the evolution of the Diagnostic and Statistical Manual of Mental Disorders. Arch Psychiatr Nurs 25:398
Moncrieff J (2010) Psychiatric diagnosis as a political device. Soc Theory Health 8:372
Pilecki BC, Clegg JW, McKay D, et al (2011) The influence of corporate and political interests on model of illness in the evolution of the DSM. Eur Psychiatry 26:195
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Glineur, C. Psychoses et cancers : puzzle épidémiologique ou brouillage de l’abord clinique des psychopathologies en oncologie ?. Psycho Oncologie 10, 256–259 (2016). https://doi.org/10.1007/s11839-016-0596-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11839-016-0596-9